-
公开(公告)号:EP4257146A1
公开(公告)日:2023-10-11
申请号:EP21900451.2
申请日:2021-11-24
IPC分类号: A61K45/00 , A61K31/517 , A61K31/7088 , A61K31/7105 , A61K31/713 , A61K39/395 , A61P35/00 , A61P35/02 , A61P43/00 , C07K16/18 , C07K16/22 , C07K16/28 , C12N15/113 , C12N15/115 , C12N15/12 , C12Q1/68 , G01N33/53 , G01N33/574
摘要: A pharmaceutical composition for preventing or treating cystic lymphangioma comprising an agent that causes suppression of expression of amphiregulin, suppression of secretion of amphiregulin, and/or inhibition of binding of amphiregulin with an amphiregulin receptor, or an agent that causes suppression of expression of an amphiregulin receptor, suppression of activation of an amphiregulin receptor, and/or inhibition of binding of an amphiregulin receptor with amphiregulin, as an active ingredient.